Issels Integrative Immuno-Oncology May 24, 2018  

Immunotherapy Adds Time to Terminal Cancer Diagnosis

Dear Friend,

At one time, a diagnosis of terminal cancer left little hope. Today, astounding developments in cancer treatment have created a segment of "super survivors" who live long past their terminal diagnosis.

Living with "Terminal" Cancer?

Canadian teacher Anne-Marie Cerato is a prime example of the new super survivors. Eight years ago, at the age of 32, non-smoker Cerato underwent treatment for lung cancer. Two years later, doctors found that the cancer had spread to Cerato's other lung and she was diagnosed as terminal.

Cerato decided to quit her job and spend her remaining months traveling the world. Amazingly, months stretched into years, and Cerato has not only married but is considering a return to teaching.

The key to Cerato's survival has been two pills a day of a drug called lorlatinib, which she takes as part of a clinical trial. Cerato's tumors carry a rare gene reassignment, making her cancer the type that lorlatinib is designed to treat.

New Cancer Treatment Provides Hope

According to Dr. Mark Doherty, an oncologist in Toronto, clinical trials of lung cancer immunotherapy treatments have resulted in 20 percent of patients surviving the five-year point. Doherty pointed out that this response was "unheard of" with previous chemotherapy drugs.

These patients are not considered cured. Rather, their diagnosis changes from a terminal illness to a chronic but treatable disease. Doctors follow up with regular scans to make sure the cancer has not progressed.

State-of-the-Art Immunotherapy from Issels®

Our founder, Dr. Josef Issels, was ahead of his time in developing non-toxic, personally tailored immunotherapy cancer treatments. Contact us to learn how we are carrying on his legacy of complete long-term remission of stage IV standard treatment-resistant cancers.

Email   Facebook   Twitter   Google+

Immunotherapy Adds Time to Terminal Cancer Diagnosis

Read more interesting articles on the "Issels Cancer Immunotherapy" news/blog posted every Tuesday and Thursday. Check It Out Now »

Focusing on a Cancer's Host Tissue May Bring a Prognosis into Better Focus

Thanks to innovations in testing methods and proactive awareness campaigns, doctors are able to diagnose cancer earlier than ever, increasing the chances of successful cancer immunotherapy. The second part of the equation, predicting the degree of malignancy, is a puzzle that remains to be solved. For the most part, researchers have concentrated on unraveling the mysteries of cancer cells themselves to understand how they grow and spread. In keeping with that approach, scientists believed that metastasis was caused by cells spreading outward from their original location.

Get the Full Story!

New Innovations in Cancer Care Are Changing Your Prognosis

Innovations are helping more people than ever survive cancer, while enjoying a better quality of life throughout treatment. People in stage four cancer treatment can enjoy effective treatment and an easier experience when receiving lower doses of certain medications, or less frequent treatments. Patients can more easily focus on holistic cancer treatment while taking less medication. Breakthroughs, innovations, and new alternative cancer treatments continue to revolutionize patients’ outlook and quality of life.

Get the Full Story!

Videos – What Do Patients Say About Their Experience?

Watch videos of patients who share their own experiences at the Issels clinics with you. Listen to their stories and cancer journeys.

Get the Full Story!

Learn More

Testimonials »

Treatments »

Vaccines »

Statistics »

History »

Locations »

Contact Us »

Connect With Us:

Google +

Contact Info:

Phone: 888-447-7357


Treatments | Testimonials | Contact Us